Key result
Small ANP analogues including A68828 demonstrate full agonist activity at both major ANP receptors.
Population
Preclinical models for evaluating atrial natriuretic peptide (ANP) receptor activation
Comparison
Small atrial natriuretic peptide analogs vs Native atrial natriuretic peptide ANP (1-28)
Design
Preclinical
Authors
Loading...
Supports exploration of ANP analogues for renal protection; leaves open translation to human efficacy.
Small ANP analogs like A68828 can be synthesized to retain full agonist activity at ANP receptors, offering potential therapeutic applications such as preventing acute renal failure.
Geldern et al. (1992) studied Acute renal failure (target condition). Small atrial natriuretic peptide analogues (e.g., A68828) was evaluated on Guanylate cyclase activation and ANP receptor binding. Small atrial natriuretic peptide analogues, including A68828, were synthesized and demonstrated full ANP agonist activity at both major ANP receptors.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: